Cargando…
New Insights in Phenothiazinium-Mediated Photodynamic Inactivation of Candida Auris
In recent years, Candida auris has emerged as a hazardous hospital-acquired pathogen. Its resistance to antifungal treatments makes it challenging, requiring new approaches to manage it effectively. Herein, we aimed to assess the impact of photodynamic inactivation mediated by methylene blue (MB-PDI...
Autores principales: | Silva, Abdênego R., Cabral, Fernanda V., Silva, Camila R., Silva, Daniela F. T., Freitas, Anderson Z., Fontes, Adriana, Ribeiro, Martha S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381569/ https://www.ncbi.nlm.nih.gov/pubmed/37504706 http://dx.doi.org/10.3390/jof9070717 |
Ejemplares similares
-
Phenothiazinium Photosensitizers Associated with Silver Nanoparticles in Enhancement of Antimicrobial Photodynamic Therapy
por: Rigotto Caruso, Glaucia, et al.
Publicado: (2021) -
Photodynamic Therapy Is Effective Against Candida auris Biofilms
por: Bapat, Priyanka S., et al.
Publicado: (2021) -
New insights in photodynamic inactivation of Leishmania amazonensis: A focus on lipidomics and resistance
por: Cabral, Fernanda V., et al.
Publicado: (2023) -
Comparative Study on the Efficiency of the Photodynamic Inactivation of Candida albicans Using CdTe Quantum Dots, Zn(II) Porphyrin and Their Conjugates as Photosensitizers
por: Viana, Osnir S., et al.
Publicado: (2015) -
Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro
por: Bulhões Portapilla, Gisele, et al.
Publicado: (2019)